Curaleaf Launches NY’s First Medical Cannabis Flower Products
Now available for limited release, Curaleaf will provide New York’s medical cannabis patients a new method to take their medicine by offering ground flower pods, which are used in medical vaporizers. Each Curaleaf Ground Flower Pod contains 350mg of active cannabinoids — a total of 700mg per 3.5g package.
“Curaleaf is very pleased to be launching the first medical cannabis flower products to be offered in New York state, which is first and foremost a win for our patients,” said Joseph Lusardi, CEO of Curaleaf. “Flower is cannabis in its raw form and therefore the most affordable form of cannabis. We can increase patient access by providing more affordable products and offering more options for patients in the medical program.”
For more information, go to www.curaleaf.com.